Adial Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.13-$7.20 |
Market Cap | $13.2M |
Shares Short | 179,569 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$20.65 |
News
See moreYahoo Finance • 7 days ago
Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis
Yahoo Finance • 5 months ago
Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...
Yahoo Finance • 5 months ago
Sector Update: Healthcare Stocks Higher Late Afternoon
Yahoo Finance • 5 months ago
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
About
CEO | Mr. Cary John Claiborne MBA |
CFO | Mr. Vinay Shah A.C.A., C.P.A., M.B.A. |
Address | 4870 Sadler Road, Glen Allen, VA, United States, 23060 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |